Human Genome Epidemiology Literature Finder
Records 1 - 19 (of 19 Records) |
Query Trace: Oligodendroglioma and TP53[original query] |
---|
Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 2002 1 8 (1): 196-201. Ueki Keisuke, Nishikawa Ryo, Nakazato Yoichi, Hirose Takanori, Hirato Junko, Funada Nobuaki, Fujimaki Takamitsu, Hojo Shuntaro, Kubo Osami, Ide Takafumi, Usui Masaaki, Ochiai Chikayuki, Ito Shoichi, Takahashi Hiroshi, Mukasa Akitake, Asai Akio, Kirino Takaa |
Molecular classification of low-grade diffuse gliomas. The American journal of pathology 2010 Dec 177 (6): 2708-14. Kim Young-Ho, Nobusawa Sumihito, Mittelbronn Michel, Paulus Werner, Brokinkel Benjamin, Keyvani Kathy, Sure Ulrich, Wrede Karsten, Nakazato Yoichi, Tanaka Yuko, Vital Anne, Mariani Luigi, Stawski Robert, Watanabe Takuya, De Girolami Umberto, Kleihues Paul, Ohgaki Hiro |
IDH1 and IDH2 mutations, immunohistochemistry and associations in a series of brain tumors. Journal of neuro-oncology 2011 Nov 105 (2): 345-57. Mellai Marta, Piazzi Angela, Caldera Valentina, Monzeglio Oriana, Cassoni Paola, Valente Guido, Schiffer Davi |
Molecular markers in low-grade gliomas: predictive or prognostic? Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Jul 17 (13): 4588-99. Hartmann Christian, Hentschel Bettina, Tatagiba Marcos, Schramm Johannes, Schnell Oliver, Seidel Clemens, Stein Robert, Reifenberger Guido, Pietsch Torsten, von Deimling Andreas, Loeffler Markus, Weller Michael, |
Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas. Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Jun 20 (11): 2898-909. Wakimoto Hiroaki, Tanaka Shota, Curry William T, Loebel Franziska, Zhao Dan, Tateishi Kensuke, Chen Juxiang, Klofas Lindsay K, Lelic Nina, Kim James C, Dias-Santagata Dora, Ellisen Leif W, Borger Darrell R, Fendt Sarah-Maria, Vander Heiden Matthew G, Batchelor Tracy T, Iafrate A John, Cahill Daniel P, Chi Andrew |
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin |
Immunohistochemical profiles of IDH1, MGMT and P53: practical significance for prognostication of patients with diffuse gliomas. Neuropathology : official journal of the Japanese Society of Neuropathology 2015 Aug 35 (4): 324-35. Ogura Ryosuke, Tsukamoto Yoshihiro, Natsumeda Manabu, Isogawa Mizuho, Aoki Hiroshi, Kobayashi Tsutomu, Yoshida Seiichi, Okamoto Kouichiro, Takahashi Hitoshi, Fujii Yukihiko, Kakita Akiyos |
IDH-mutated astrocytomas with 19q-loss constitute a subgroup that confers better prognosis. Cancer science 2018 May . Otani Ryohei, Uzuka Takeo, Higuchi Fumi, Matsuda Hadzki, Nomura Masashi, Tanaka Shota, Mukasa Akitake, Ichimura Koichi, Kim Phyo, Ueki Keisu |
Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 4 24 (12): 2812-2819. Martínez-Ricarte Francisco, Mayor Regina, Martínez-Sáez Elena, Rubio-Pérez Carlota, Pineda Estela, Cordero Esteban, Cicuéndez Marta, Poca Maria A, López-Bigas Nuria, Ramon Y Cajal Santiago, Vieito María, Carles Joan, Tabernero Josep, Vivancos Ana, Gallego Soledad, Graus Francesc, Sahuquillo Juan, Seoane Jo |
Clinical significance of the 2016 WHO classification in Japanese patients with gliomas. Brain tumor pathology 2018 2 35 (2): 71-80. Iuchi Toshihiko, Sugiyama Takahiro, Ohira Miki, Kageyama Hajime, Yokoi Sana, Sakaida Tsukasa, Hasegawa Yuzo, Setoguchi Taiki, Itami Maki |
von Willebrand Factor Gene Expression in Primary Lower Grade Glioma: Mutually Co-Occurring Mutations in von Willebrand Factor, ATRX, and TP53. Brain tumor research and treatment 2019 Apr 7 (1): 33-38. Lehrer Steven, Rheinstein Peter H, Green Sheryl, Rosenzweig Kenneth |
Allergy may confer better survival on patients with gliomas. Clinical neurology and neurosurgery 2019 1 177 63-67. Lehrer Steven, Rheinstein Peter H, Rosenzweig Kenneth |
Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1. Neuro-oncology advances 0 2 (1): vdaa042. Alghamri Mahmoud S, Thalla Rohit, Avvari Ruthvik P, Dabaja Ali, Taher Ayman, Zhao Lili, Ulintz Peter J, Castro Maria G, Lowenstein Pedro |
Polymorphous Low-Grade Neuroepithelial Tumor of the Young (PLNTY): Molecular Profiling Confirms Frequent MAPK Pathway Activation. Journal of neuropathology and experimental neurology 2021 8 80 (9): 821-829. Ida Cristiane M, Johnson Derek R, Nair Asha A, Davila Jaime, Kollmeyer Thomas M, Minn Kay, Fadra Numrah M, Balcom Jessica R, Fung Kar-Ming A, Kim Dong Kun, Kaufmann Timothy J, Kipp Benjamin R, Halling Kevin C, Jenkins Robert B, Giannini Cateri |
Molecular Pathology of Gliomas. Surgical pathology clinics 2021 8 14 (3): 379-386. Galbraith Kristyn, Snuderl Mati |
TP53 Mutation Is a Prognostic Factor in Lower Grade Glioma and May Influence Chemotherapy Efficacy. Cancers 2021 11 13 (21): . Noor Humaira, Briggs Nancy E, McDonald Kerrie L, Holst Jeff, Vittorio Oraz |
PTPRD and CNTNAP2 as markers of tumor aggressiveness in oligodendrogliomas. Scientific reports 2022 8 12 (1): 14083. Rautajoki Kirsi J, Jaatinen Serafiina, Tiihonen Aliisa M, Annala Matti, Vuorinen Elisa M, Kivinen Anni, Rauhala Minna J, Maass Kendra K, Pajtler Kristian W, Yli-Harja Olli, Helén Pauli, Haapasalo Joonas, Haapasalo Hannu, Zhang Wei, Nykter Mat |
Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26. Neuro-oncology 2022 12 . Alpen Karen, Vajdic Claire M, MacInnis Robert J, Milne Roger L, Koh Eng-Siew, Hovey Elizabeth, Harrup Rosemary, Bruinsma Fiona, Nguyen Tuong L, Li Shuai, Joseph David, Benke Geza, Dugué Pierre-Antoine, Southey Melissa C, Giles Graham G, Rosenthal Mark, Drummond Katharine J, Nowak Anna K, Hopper John L, Kapuscinski Miroslaw, Makalic En |
Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis. Scientific reports 2023 5 13 (1): 6761. Kwanghoon Lee, Seong-Ik Kim, Eric Eunshik Kim, Yu-Mi Shim, Jae-Kyung Won, Chul-Kee Park, Seung Hong Choi, Hongseok Yun, Hyunju Lee, Sung-Hye Pa |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: